These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1178 related items for PubMed ID: 18801366

  • 1. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
    Lim SO, Gu JM, Kim MS, Kim HS, Park YN, Park CK, Cho JW, Park YM, Jung G.
    Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
    [Abstract] [Full Text] [Related]

  • 2. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.
    Park IY, Sohn BH, Yu E, Suh DJ, Chung YH, Lee JH, Surzycki SJ, Lee YI.
    Gastroenterology; 2007 Apr; 132(4):1476-94. PubMed ID: 17408664
    [Abstract] [Full Text] [Related]

  • 3. Frequent promoter methylation of M-cadherin in hepatocellular carcinoma is associated with poor prognosis.
    Yamada S, Nomoto S, Fujii T, Takeda S, Kanazumi N, Sugimoto H, Nakao A.
    Anticancer Res; 2007 Apr; 27(4B):2269-74. PubMed ID: 17695513
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
    Kao RH, Huang LC, Hsu YH.
    Anticancer Res; 2002 Apr; 22(6C):4109-13. PubMed ID: 12553040
    [Abstract] [Full Text] [Related]

  • 6. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
    Wei Y, Van Nhieu JT, Prigent S, Srivatanakul P, Tiollais P, Buendia MA.
    Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
    [Abstract] [Full Text] [Related]

  • 7. Cadherin/catenin complex appears to be intact in hepatocellular carcinomas from Australia and South Africa.
    Herath NI, Walsh MD, Kew MC, Young J, Leggett BA, Macdonald GA.
    J Gastroenterol Hepatol; 2004 Jun; 19(6):676-82. PubMed ID: 15151624
    [Abstract] [Full Text] [Related]

  • 8. Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance.
    Chang HW, Chow V, Lam KY, Wei WI, Yuen A.
    Cancer; 2002 Jan 15; 94(2):386-92. PubMed ID: 11900224
    [Abstract] [Full Text] [Related]

  • 9. Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas.
    Matsumura T, Makino R, Mitamura K.
    Clin Cancer Res; 2001 Mar 15; 7(3):594-9. PubMed ID: 11297254
    [Abstract] [Full Text] [Related]

  • 10. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
    Lu B, Ma Y, Wu G, Tong X, Guo H, Liang A, Cong W, Liu C, Wang H, Wu M, Zhao J, Guo Y.
    Clin Cancer Res; 2008 Nov 15; 14(22):7405-12. PubMed ID: 19010857
    [Abstract] [Full Text] [Related]

  • 11. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
    Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Qiyong L, Fujii T, Sugimoto H, Takeda S, Nakao A.
    Ann Surg Oncol; 2010 Mar 15; 17(3):923-32. PubMed ID: 19898900
    [Abstract] [Full Text] [Related]

  • 12. Reduced T-cadherin expression and promoter methylation are associated with the development and progression of hepatocellular carcinoma.
    Yan Q, Zhang ZF, Chen XP, Gutmann DH, Xiong M, Xiao ZY, Huang ZY.
    Int J Oncol; 2008 May 15; 32(5):1057-63. PubMed ID: 18425332
    [Abstract] [Full Text] [Related]

  • 13. [Studies of promoter methylation status and protein expression of E-cadherin gene in associated progression stages of gastric cancer].
    Zheng ZH, Sun XJ, Ma MC, Hao DM, Liu YH, Sun KL.
    Yi Chuan Xue Bao; 2003 Feb 15; 30(2):103-8. PubMed ID: 12776596
    [Abstract] [Full Text] [Related]

  • 14. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features.
    Kim DS, Kim MJ, Lee JY, Kim YZ, Kim EJ, Park JY.
    Cancer; 2007 Dec 15; 110(12):2785-92. PubMed ID: 17960794
    [Abstract] [Full Text] [Related]

  • 15. Epigenetic regulation of hTERT promoter in hepatocellular carcinomas.
    Iliopoulos D, Satra M, Drakaki A, Poultsides GA, Tsezou A.
    Int J Oncol; 2009 Feb 15; 34(2):391-9. PubMed ID: 19148473
    [Abstract] [Full Text] [Related]

  • 16. Promoter hypermethylation profile of ovarian epithelial neoplasms.
    Makarla PB, Saboorian MH, Ashfaq R, Toyooka KO, Toyooka S, Minna JD, Gazdar AF, Schorge JO.
    Clin Cancer Res; 2005 Aug 01; 11(15):5365-9. PubMed ID: 16061849
    [Abstract] [Full Text] [Related]

  • 17. DNA methyltransferase 1 expression and promoter methylation of E-cadherin in mucoepidermoid carcinoma.
    Shieh YS, Shiah SG, Jeng HH, Lee HS, Wu CW, Chang LC.
    Cancer; 2005 Sep 01; 104(5):1013-21. PubMed ID: 15999364
    [Abstract] [Full Text] [Related]

  • 18. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
    Gho JW, Ip WK, Chan KY, Law PT, Lai PB, Wong N.
    Cancer Res; 2008 Aug 15; 68(16):6743-51. PubMed ID: 18701499
    [Abstract] [Full Text] [Related]

  • 19. Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo.
    Hennig G, Behrens J, Truss M, Frisch S, Reichmann E, Birchmeier W.
    Oncogene; 1995 Aug 03; 11(3):475-84. PubMed ID: 7630631
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.